Divergent Cell-Type Specific Hypoxia Responses in Human Stem Cell–Derived and Primary Islets
Listed in
This article is not in any list yet, why not save it to one of your lists.Abstract
Background
The success of stem cell-derived islet (SC-islet) therapy for type 1 diabetes is limited by poor graft survival in the hypoxic post-transplantation microenvironment. While the response of SC-islets to chronic hypoxia has been studied, a direct comparison to primary human islets during the acute hypoxic phase has not been performed. Here, we conduct a comparative single-cell transcriptomic and functional analysis of human SC-islets and primary islets exposed to acute hypoxia (1% O 2 ) over 48 hours.
Results
Our analysis reveals two divergent response patterns. Primary islets exhibit an energy-conserving response, characterized by a β-cell-specific suppression of identity genes ( PDX1 , MAFA ) and pro-apoptotic factors like DDIT3 , alongside a shift toward metabolic quiescence. In contrast, the SC-islet response is characterized by lineage instability, a significant metabolic shift toward glycolysis, and the activation of pro-apoptotic pathways. Functionally, these transcriptomic differences result in a loss of glucose-stimulated insulin secretion in both islet types, but through different mechanisms: a suppression of secretion in primary islets versus dysregulated, glucose-unresponsive insulin release in SC-islets.
Conclusion
These findings demonstrate that SC-islets are particularly vulnerable under hypoxic stress, exhibiting an unstable, plastic phenotype. This comparative dataset provides a resource for developing source-specific therapeutic interventions to overcome the hypoxic barrier and improve the efficacy of cell replacement therapies.
